$NXTC NextCure, Inc. Insider Trading
Get free email notifications about insider trading in NextCure, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NextCure, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in NextCure, Inc. for free.
CIK Number: 0001661059
IRS Number: 475231247
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NXTC
Company Address: 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE 20705
Phone number: 240-399-4900
NextCure, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | NXTC | NextCure, Inc. | Nicholson Garry A | Director | Option Exercise | A | 8.21 | 14,250 | 116,993 | 14,250 | |
Jun 28 2021 | NXTC | NextCure, Inc. | Jones Elaine V | Director | Option Exercise | A | 8.21 | 14,250 | 116,993 | 14,250 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Richman Michael | President & CEO | Option Exercise | A | 12.59 | 300,000 | 3,777,000 | 300,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Mayer Timothy | Chief Operating Off ... | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Richman Michael | President & CEO | Option Exercise | A | 12.59 | 300,000 | 3,777,000 | 300,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Liu Linda | SVP, Research | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Langermann Sol | Chief Scientific Of ... | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Mayer Timothy | Chief Operating Off ... | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Liu Linda | SVP, Research | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Cobourn Steven P. | Chief Financial Off ... | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Langermann Sol | Chief Scientific Of ... | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Mar 16 2021 | NXTC | NextCure, Inc. | Cobourn Steven P. | Chief Financial Off ... | Option Exercise | A | 12.59 | 100,000 | 1,259,000 | 100,000 | |
Jan 19 2021 | NXTC | NextCure, Inc. | Myint Han | Chief Medical Offic ... | Option Exercise | A | 12.09 | 200,000 | 2,418,000 | 200,000 | |
Sep 14 2020 | NXTC | NextCure, Inc. | Houston John G | Director | Option Exercise | A | 9.14 | 10,687 | 97,679 | 10,687 | |
Sep 14 2020 | NXTC | NextCure, Inc. | Houston John G | Director | Option Exercise | A | 9.14 | 28,500 | 260,490 | 28,500 |